Skip to main content
Log in

Kinetic-Effect Models and Their Applications

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

This article focuses on mathematical models that analyze the time course of drug effects in humans. Any such model, whether parametric or nonparametric, is termed a kinetic-effect model (KEM). These models serve to describe (interpolation) and to predict (extrapolation) the effect–time profile. KEMs are applicable to many problems in pharmaceutics, pharmacology, and clinical pharmacology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. V. F. Smolen. In H. S. Bean, A. H. Beckett, and J. E. Carless (eds.), Advances in Pharmaceutical Sciences, Vol. 5, Academic Press, London, 1982, pp. 117–200.

    Google Scholar 

  2. G. Segre. Farm. Sci. Ed. 23:907–918 (1968).

    Google Scholar 

  3. N. H. G. Holford and L. B. Sheiner. Clin. Pharmacokin. 6:429–453 (1981).

    Google Scholar 

  4. N. H. G. Holford and L. B. Sheiner. CRC Crit. Rev. Bioeng. 7:273–322 (1981).

    Google Scholar 

  5. D. J. Coltart and D. G. Shand. Br. Med. J. 3:731–734 (1970).

    Google Scholar 

  6. J. G. Wagner, G. K. Aghajanian, and O. H. L. Bing. Clin. Pharmacol. Ther. 9:635–638 (1968).

    Google Scholar 

  7. R. L. Galeazzi, L. Z. Benet, and L. B. Sheiner. Clin. Pharmacol. Ther. 20:278–289 (1976).

    Google Scholar 

  8. L. B. Sheiner, D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. Clin. Pharmacol. Ther. 25:358–371 (1979).

    Google Scholar 

  9. J. D. Unadkat, F. Bartha, and L. B. Sheiner. Clin. Pharmacol. Ther. 40:86–93 (1986).

    Google Scholar 

  10. J. Grevel. J. Cardiovasc. Pharmacol. 8(Suppl. 6):S16–S19 (1986).

    Google Scholar 

  11. N. H. G. Holford. Pharm. Res. 1:102–105 (1984).

    Google Scholar 

  12. J. Grevel. In P. A. Van Zwieten (ed.), The Position of Bopindolol, Roy. Soc. Med. Ser., London, 1986, pp. 49–54.

  13. J. Grevel, J. Brownell, J. L. Steimer, R. C. Gaillard, and J. Rosenthaler. Br. J. Clin. Pharmacol. 22:1–13 (1986).

    Google Scholar 

  14. L. B. Sheiner and S. L. Beal. J. Pharmacokin. Biopharm. 9:503–512 (1981).

    Google Scholar 

  15. J. Grevel, J. Brownell, P. Guitard, and J. Rosenthaler. In J. C. Frölich (ed.), Plasmaspiegel—Wirkungsbeziehungen von Pharmaka, G. Fischer Verlag, Stuttgart, 1986, pp. 125–141.

    Google Scholar 

  16. K. J. Åström. In R. Bellman (ed.), Introduction to Stochastic Control Theory, Mathematics in Science and Engineering, Vol. 70, Academic Press, New York, 1970.

    Google Scholar 

  17. D. A. Linkens. In D. Ingram and R. F. Bloch (eds.), Mathematical Methods in Medicine. Part I. Statistical and Analytical Techniques, John Wiley, New York, 1984, pp. 405–430.

    Google Scholar 

  18. S. Vozeh and J. L. Steimer. Clin. Pharmacokin. 10:457–476 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grevel, J. Kinetic-Effect Models and Their Applications. Pharm Res 4, 86–91 (1987). https://doi.org/10.1023/A:1016402616081

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016402616081

Navigation